Compare Ginkgo Bioworks Holdings Inc (DNA) vs Expedia Group Inc (EXPE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Expedia Group Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Expedia Group Inc trades at $328 (market cap $38.53B). The key difference: Expedia Group Inc is far larger — about 76.2× Ginkgo Bioworks Holdings Inc's market cap, and Expedia Group Inc pays a 0.6% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | EXPE | |
|---|---|---|
Market Cap | $505.73M | $38.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $16.14 | $321.07 |
52-Week Low | $5.48 | $188.51 |
Enterprise Value | $607.68M | $37.09B |
Dividend Yield | — | 0.6% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Expedia Group Inc
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →
